Therapeutic outcomes of 68 cases with oropharyngeal squamous cell carcinoma referring to UICC version 7 and 8

Akihiro Tamae, Masanobu Sato, Hidetaka Yamamoto, Teppei Noda, Kazuo Nishiyama, Koichiro Nakashima, Ryuji Yasumatsu

研究成果: Contribution to journalArticle

抜粋

We retrospectively reviewed the records of 68 patients with oropharyngeal squamous cell carcinoma who had undergone initial treatment in the Department of Otolaryngology, Head and Neck Surgery, Hamanomachi Hospital between 2009 and 2017. We compared therapeutic outcomes of p16-positive with p16-negative cases, referring to Unio Internationalis Contra Cancrum(UICC)diagnostic criteria version 7 and 8. Of 68(58.5%)patients, 38 were diagnosed as p16-positive. The 3-year disease-specific survival rate of all patients, p16-positive, and p16-negative patients were 78.5%, 74.1%, and 84.7%, respectively. Referring to UICC version 8, the 3-year disease-specific survival rate(3DSS)of p16-negative patients in each clinical stage was stage Ⅱ: 100%, stageⅢ: 66.7%, and stage Ⅳa: 70.6%, whereas 3DSS of p16-positive patients was stage I: 93.8%, stageⅡ: 83.3%, stageⅢ: 77.1%, and stage Ⅳ: 0%.

元の言語英語
ページ(範囲)59-63
ページ数5
ジャーナルJapanese Journal of Head and Neck Cancer
46
発行部数1
DOI
出版物ステータス出版済み - 2020

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Oncology

フィンガープリント Therapeutic outcomes of 68 cases with oropharyngeal squamous cell carcinoma referring to UICC version 7 and 8' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用